Gloves stay strong, with fears over vaccine’s safety


Virus boost: Concerns on the safety of a vaccine for the coronavirus has allowed glove stocks to sustain their gains, while pharmaceutical counters are also seeing some uptrend.

PETALING JAYA: The efficacy of a potential Covid-19 vaccine continues to be a concern even as the need for it becomes prevalent.

This has allowed glove stocks to sustain their gains, while pharmaceutical counters are also seeing some gains, but not yet a strong interest moving into their shares.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

China’s surplus crude oil eased in October, but this is still bearish
Australia to safeguard cash payments
Methane from tropical wetlands surges, threatening climate plans
Trump’s scoreboard is Wall Street’s best hope
Biden tours Amazon, says clean energy here to stay
UK inflation may call for more caution
Abu Dhabi firms propel bourses to US$1 trillion
Investors eye IPO access with Hong Kong link
Hanoi to plan for more disaster-risk financing
Treasuries see 2024 gains dwindle with December Fed cut at risk

Others Also Read